Clinical Research Directory
Browse clinical research sites, groups, and studies.
Plantar Fasciitis Randomized Clinical Control Trial
Sponsor: University of Pennsylvania
Summary
The primary aim of this clinical experiment is to compare, in terms of pain relief measured using the 10-cm visual analog scale (VAS) pain score (5-7), the clinical results of ultrasound-guided injection (USGI) versus anatomic topography-guided injection (ATGI) of corticosteroid for the treatment of proximal PF. Secondary aims will be to compare foot-related quality of life, as measured using the Foot Function Index (FFI)and the Bristol Foot Score (BFS), between the injection groups, and also to compare the pre-injection to late-term post-injection thickness of the plantar fascia as measured in the nested USGI group.
Official title: Randomized Clinical Study to Evaluate Ultrasound Guided Injection Therapy Versus Topographic Injection Therapy for Plantar Fasciitis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
62
Start Date
2017-03-28
Completion Date
2026-10-31
Last Updated
2025-10-10
Healthy Volunteers
Yes
Conditions
Interventions
Local Steroid Injection into the plantar heel
Injections consisting of 0.5 ml 0.25% bupivacaine plain, 0.5 ml dexamethasone phosphate, and 0.5 ml triamcinolone acetonide 40 mg/ml.
Ultrasound Guided Injection
Execution of the USGI will employ an actual diagnostic US machine (Voluson E8 Expert, General Electric Company, Boston, MA) and a plantarmedial approach
Anatomical Guided injection
Execution of the ATGI will employ a sham diagnostic US machine and a plantarmedial approach.
Locations (1)
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, United States